Ex-Pharma CEO Charged With Inside Trading Over Teva Deal
The former CEO of Auspex Pharmaceuticals Inc. tipped off his inner circle ahead of the company's $3.2 billion acquisition by Teva Pharmaceutical Industries Ltd. in 2015, prosecutors and the U.S. Securities...To view the full article, register now.
Already a subscriber? Click here to view full article